SPOTLIGHT: Millennium chief gets lucrative deal

Deborah Dunsire's new job as CEO of Millennium came with a million-dollar payment to cover her unvested options in Novartis stock. She also pocketed a $300,000 signing bonus, an $800,000 annual salary, a bonus plan and options in Millennium stock. Story

Suggested Articles

The Pfizer Foundation has awarded 20 grants to organizations involved in tackling infectious diseases in low- and middle-income countries.

The engineered stain of E. coli performed no better than placebo, leading Synlogic to conclude its money is better spent on other assets.

The FDA rejected the New Drug Application for golodirsen, the follow-up to Exondys 51, Sarepta’s first treatment for Duchenne muscular dystrophy.